Finally, we analyzed the anti-tumor activity and toxicity of 1-Au/TNF and 2-Au/TNF using nanodrug doses equivalent to 3 μg of bioactive TNF, administered intravenously to immunocompetent mice bearing subcutaneous WEHI-164 fibrosarcomas. The gene discussed is TNF; the disease is fibrosarcoma.